Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2P3T

Crystal structure of human factor XA complexed with 3-Chloro-4-(2-methylamino-imidazol-1-ylmethyl)-thiophene-2-carboxylic acid [4-chloro-2-(5-chloro-pyridin-2-ylcarbamoyl)-6-methoxy-phenyl]-amide

Summary for 2P3T
Entry DOI10.2210/pdb2p3t/pdb
Related1EZQ 1F0R 1F0S 1FJS 1MQ5 1MQ6 2P3U
DescriptorCoagulation factor X, CALCIUM ION, CHLORIDE ION, ... (6 entities in total)
Functional Keywordsprotein inhibitor complex, nonamidine, coagulation cofactor, protease, blood clotting
Biological sourceHomo sapiens (human)
More
Cellular locationSecreted: P00742 P00742
Total number of polymer chains2
Total formula weight32576.62
Authors
Adler, M.,Whitlow, M. (deposition date: 2007-03-09, release date: 2008-01-22, Last modification date: 2024-11-06)
Primary citationYe, B.,Arnaiz, D.O.,Chou, Y.L.,Griedel, B.D.,Karanjawala, R.,Lee, W.,Morrissey, M.M.,Sacchi, K.L.,Sakata, S.T.,Shaw, K.J.,Wu, S.C.,Zhao, Z.,Adler, M.,Cheeseman, S.,Dole, W.P.,Ewing, J.,Fitch, R.,Lentz, D.,Liang, A.,Light, D.,Morser, J.,Post, J.,Rumennik, G.,Subramanyam, B.,Sullivan, M.E.,Vergona, R.,Walters, J.,Wang, Y.X.,White, K.A.,Whitlow, M.,Kochanny, M.J.
Thiophene-anthranilamides as highly potent and orally available factor xa inhibitors.
J.Med.Chem., 50:2967-2980, 2007
Cited by
PubMed Abstract: There remains a high unmet medical need for a safe oral therapy for thrombotic disorders. The serine protease factor Xa (fXa), with its central role in the coagulation cascade, is among the more promising targets for anticoagulant therapy and has been the subject of intensive drug discovery efforts. Investigation of a hit from high-throughput screening identified a series of thiophene-substituted anthranilamides as potent nonamidine fXa inhibitors. Lead optimization by incorporation of hydrophilic groups led to the discovery of compounds with picomolar inhibitory potency and micromolar in vitro anticoagulant activity. Based on their high potency, selectivity, oral pharmacokinetics, and efficacy in a rat venous stasis model of thrombosis, compounds ZK 814048 (10b), ZK 810388 (13a), and ZK 813039 (17m) were advanced into development.
PubMed: 17536795
DOI: 10.1021/jm070125f
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.92 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon